Skip to content
Disclosery

Boxer Capital, LLC

Follow

13F filer, CIK 1465837, San Diego, CA

Boxer Capital, LLC reported $1,898,904,676 across 61 holdings for the quarter ended 2024-06-30, in a 13F-HR filed 2024-08-14. Its ten largest share positions make up 54.31% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000895345-24-000355

Period
2024-06-30
Reported value
$1.9B
Holdings
61
Top 10 weight
54.31%
New
4
Sold out
2

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CLYMnew+2,603,190$18.5M
ITEOS THERAPEUTICS INCadded+1,142,857$17M
REPLnew+1,536,341$13.8M
CGEMnew+657,895$11.5M
SYREadded+446,480$10.5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ATARA BIOTHERAPEUTICS INC C…reduced-3,984,000-$33.9M
VKTXexited-300,000-$24.6M
DIREXION SHS ETF TRexited-350,000-$2.55M
DBV TECHNOLOGIES S Areduced-250,000-$200K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2024

Share positions as resolved from 13F-HR 0000895345-24-000355, largest first. % of portfolio is the value over $1,898,904,676, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 4,684,264 shares; 2023Q2: 4,684,264 shares; 2023Q3: 4,684,264 shares; 2023Q4: 4,279,464 shares; 2024Q1: 4,279,464 shares; 2024Q2: 4,279,464 shares 4,279,464$166M8.75%0Timeline
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 3,421,541 shares; 2023Q2: 3,421,541 shares; 2023Q3: 3,421,541 shares; 2023Q4: 3,421,541 shares; 2024Q1: 3,421,541 shares; 2024Q2: 3,421,541 shares 3,421,541$129M6.79%0
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,100,000 shares; 2023Q2: 2,100,000 shares; 2023Q3: 2,100,000 shares; 2023Q4: 2,100,000 shares; 2024Q1: 2,100,000 shares; 2024Q2: 2,100,000 shares 2,100,000$114M5.99%0Timeline
MERUS N VMERUS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,900,000 shares; 2023Q2: 1,900,000 shares; 2023Q3: 1,900,000 shares; 2023Q4: 1,900,000 shares; 2024Q1: 1,900,000 shares; 2024Q2: 1,900,000 shares 1,900,000$112M5.92%0
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 6,448,359 shares; 2023Q2: 6,448,359 shares; 2023Q3: 6,448,359 shares; 2023Q4: 6,448,359 shares; 2024Q1: 6,448,359 shares; 2024Q2: 6,448,359 shares 6,448,359$103M5.43%0Timeline
SRPTSAREPTA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 775,000 shares; 2023Q2: 600,000 shares; 2023Q3: 600,000 shares; 2023Q4: 650,000 shares; 2024Q1: 650,000 shares; 2024Q2: 650,000 shares 650,000$103M5.41%0Timeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,210,192 shares; 2023Q2: 1,210,192 shares; 2023Q3: 1,210,192 shares; 2023Q4: 1,120,192 shares; 2024Q1: 1,120,192 shares; 2024Q2: 1,120,192 shares 1,120,192$85M4.48%0Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,202,812 shares; 2023Q2: 2,202,812 shares; 2023Q3: 2,202,812 shares; 2023Q4: 2,202,812 shares; 2024Q1: 2,202,812 shares; 2024Q2: 2,202,812 shares 2,202,812$77.3M4.07%0Timeline
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 500,000 shares; 2023Q2: 500,000 shares; 2023Q3: 500,000 shares; 2023Q4: 500,000 shares; 2024Q1: 500,000 shares; 2024Q2: 500,000 shares 500,000$71.3M3.76%0Timeline
RNAMAVIDITY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,121,327 shares; 2023Q2: 1,121,327 shares; 2023Q3: 1,121,327 shares; 2023Q4: 1,121,327 shares; 2024Q1: 1,727,388 shares; 2024Q2: 1,727,388 shares 1,727,388$70.6M3.72%0Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 7,123,642 shares; 2023Q2: 7,123,642 shares; 2023Q3: 7,123,642 shares; 2023Q4: 8,198,642 shares; 2024Q1: 8,198,642 shares; 2024Q2: 8,198,642 shares 8,198,642$70.3M3.7%0Timeline
APLSAPELLIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,576,000 shares; 2023Q2: 1,576,000 shares; 2023Q3: 1,726,000 shares; 2023Q4: 1,726,000 shares; 2024Q1: 1,726,000 shares; 2024Q2: 1,726,000 shares 1,726,000$66.2M3.49%0Timeline
ITEOS THERAPEUTICS INCITEOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,154,058 shares; 2023Q2: 2,154,058 shares; 2023Q3: 1,804,058 shares; 2023Q4: 1,804,058 shares; 2024Q1: 1,804,058 shares; 2024Q2: 2,946,915 shares 2,946,915$43.7M2.3%+1,142,857
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 75,000 shares; 2023Q3: 85,000 shares; 2023Q4: 160,000 shares; 2024Q1: 100,000 shares; 2024Q2: 100,000 shares 100,000$43M2.26%0Timeline
AKROAKERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 831,495 shares; 2023Q2: 1,676,733 shares; 2023Q3: 1,676,733 shares; 2023Q4: 1,676,733 shares; 2024Q1: 1,676,733 shares; 2024Q2: 1,676,733 shares 1,676,733$39.3M2.07%0Timeline
NKTXNKARTA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 1,440,000 shares; 2024Q1: 5,607,350 shares; 2024Q2: 5,607,350 shares 5,607,350$33.1M1.75%0Timeline
ANABANAPTYSBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,300,000 shares; 2023Q2: 1,300,000 shares; 2023Q3: 1,300,000 shares; 2023Q4: 1,300,000 shares; 2024Q1: 1,300,000 shares; 2024Q2: 1,300,000 shares 1,300,000$32.6M1.72%0Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 400,000 shares; 2023Q2: 400,000 shares; 2023Q3: 400,000 shares; 2023Q4: 400,000 shares; 2024Q1: 400,000 shares; 2024Q2: 400,000 shares 400,000$32.2M1.7%0Timeline
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,466,051 shares; 2023Q2: 1,466,051 shares; 2023Q3: 1,466,051 shares; 2023Q4: 1,466,051 shares; 2024Q1: 1,466,051 shares; 2024Q2: 1,466,051 shares 1,466,051$31.6M1.66%0Timeline
FATEFATE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 500,000 shares; 2023Q2: 500,000 shares; 2023Q3: 500,000 shares; 2023Q4: 500,000 shares; 2024Q1: 8,215,910 shares; 2024Q2: 8,215,910 shares 8,215,910$26.9M1.42%0Timeline
LEGNLEGEND BIOTECH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 600,000 shares; 2023Q3: 600,000 shares; 2023Q4: 600,000 shares; 2024Q1: 600,000 shares; 2024Q2: 600,000 shares 600,000$26.6M1.4%0Timeline
THRDTHIRD HARMONIC BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 570,417 shares; 2023Q2: 570,417 shares; 2023Q3: 520,417 shares; 2023Q4: 750,000 shares; 2024Q1: 2,000,000 shares; 2024Q2: 2,000,000 shares 2,000,000$26M1.37%0Timeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 3,000,000 shares; 2023Q3: 3,000,000 shares; 2023Q4: 3,000,000 shares; 2024Q1: 6,000,000 shares; 2024Q2: 6,000,000 shares 6,000,000$25.4M1.34%0Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,432,200 shares; 2023Q2: 1,602,200 shares; 2023Q3: 1,602,200 shares; 2023Q4: 1,602,200 shares; 2024Q1: 1,602,200 shares; 2024Q2: 1,602,200 shares 1,602,200$24.4M1.29%0Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 600,000 shares; 2023Q2: 600,000 shares; 2023Q3: 600,000 shares; 2023Q4: 600,000 shares; 2024Q1: 600,000 shares; 2024Q2: 600,000 shares 600,000$23.4M1.23%0Timeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 750,000 shares; 2023Q4: 1,000,000 shares; 2024Q1: 825,000 shares; 2024Q2: 825,000 shares 825,000$21.8M1.15%0Timeline
KURAKURA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 1,000,000 shares; 2024Q2: 1,000,000 shares 1,000,000$20.6M1.08%0Timeline
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,650,000 shares; 2023Q2: 1,650,000 shares; 2023Q3: 1,650,000 shares; 2023Q4: 1,650,000 shares; 2024Q1: 1,590,000 shares; 2024Q2: 1,590,000 shares 1,590,000$18.7M0.99%0Timeline
CLYMCLIMB BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: 2,603,190 shares 2,603,190$18.5M0.97%newTimeline
DAWNDAY ONE BIOPHARMACEUTICALS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,189,943 shares; 2023Q2: 1,189,943 shares; 2023Q3: 1,189,943 shares; 2023Q4: 1,189,943 shares; 2024Q1: 1,189,943 shares; 2024Q2: 1,189,943 shares 1,189,943$16.4M0.86%0Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 250,000 shares; 2024Q1: 250,000 shares; 2024Q2: 696,480 shares 696,480$16.4M0.86%+446,480Timeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 608,614 shares; 2024Q1: 608,614 shares; 2024Q2: 608,614 shares 608,614$16.2M0.85%0Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 400,000 shares; 2024Q1: 400,000 shares; 2024Q2: 400,000 shares 400,000$15.7M0.83%0Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 710,644 shares; 2023Q2: 710,644 shares; 2023Q3: 646,058 shares; 2023Q4: 646,058 shares; 2024Q1: 671,358 shares; 2024Q2: 671,358 shares 671,358$15.7M0.83%0Timeline
PRTAPROTHENA CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 300,000 shares; 2023Q2: 300,000 shares; 2023Q3: 625,000 shares; 2023Q4: 665,000 shares; 2024Q1: 690,000 shares; 2024Q2: 690,000 shares 690,000$14.2M0.75%0Timeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: 1,536,341 shares 1,536,341$13.8M0.73%newTimeline
POSEIDA THERAPEUTICS INCPOSEIDA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 4,475,000 shares; 2024Q2: 4,475,000 shares 4,475,000$13.1M0.69%0
IPSCCENTURY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 1,750,000 shares; 2024Q2: 4,901,603 shares 4,901,603$12.5M0.66%+3,151,603Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,054,000 shares; 2023Q2: 1,732,571 shares; 2023Q3: 1,732,571 shares; 2023Q4: 1,732,571 shares; 2024Q1: 1,732,571 shares; 2024Q2: 1,732,571 shares 1,732,571$12.2M0.65%0Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,169,132 shares; 2023Q2: 1,819,132 shares; 2023Q3: 1,819,132 shares; 2023Q4: 1,819,132 shares; 2024Q1: 1,819,132 shares; 2024Q2: 1,819,132 shares 1,819,132$11.9M0.62%0Timeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,074,082 shares; 2023Q2: 1,074,082 shares; 2023Q3: 1,074,082 shares; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: 657,895 shares 657,895$11.5M0.6%newTimeline
PRLDPRELUDE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 699,047 shares; 2023Q2: 2,495,018 shares; 2023Q3: 2,495,018 shares; 2023Q4: 2,568,287 shares; 2024Q1: 2,568,287 shares; 2024Q2: 2,568,287 shares 2,568,287$9.79M0.52%0Timeline
ALLOALLOGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 3,850,000 shares; 2024Q2: 3,850,000 shares 3,850,000$8.97M0.47%0Timeline
SANASANA BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 1,545,000 shares; 2024Q2: 1,545,000 shares 1,545,000$8.44M0.44%0Timeline
JSPRJASPER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 350,000 shares; 2024Q2: 350,000 shares 350,000$7.95M0.42%0Timeline
OLMAOLEMA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: 650,000 shares 650,000$7.03M0.37%newTimeline
ENGNENGENE HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 727,900 shares; 2024Q2: 727,900 shares 727,900$6.86M0.36%0Timeline
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 3,705,133 shares; 2023Q2: 3,705,133 shares; 2023Q3: 3,705,133 shares; 2023Q4: 1,400,000 shares; 2024Q1: 750,000 shares; 2024Q2: 750,000 shares 750,000$6.01M0.32%0Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,084,000 shares; 2023Q2: 2,084,000 shares; 2023Q3: 2,084,000 shares; 2023Q4: not reported; 2024Q1: 1,500,000 shares; 2024Q2: 1,500,000 shares 1,500,000$2.85M0.15%0Timeline
BOLDBOUNDLESS BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 711,329 shares; 2024Q2: 711,329 shares 711,329$2.75M0.14%0Timeline
BDTXBLACK DIAMOND THERAPEUTICS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,014,858 shares; 2023Q2: 2,014,858 shares; 2023Q3: 506,000 shares; 2023Q4: 506,000 shares; 2024Q1: 506,000 shares; 2024Q2: 506,000 shares 506,000$2.36M0.12%0Timeline
ABSIABSCI CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 700,000 shares; 2024Q2: 700,000 shares 700,000$2.16M0.11%0Timeline
OBIOORCHESTRA BIOMED HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 250,000 shares; 2023Q2: 250,000 shares; 2023Q3: 238,193 shares; 2023Q4: 238,193 shares; 2024Q1: 238,193 shares; 2024Q2: 238,193 shares 238,193$1.94M0.1%0Timeline
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 450,000 shares; 2023Q3: 450,000 shares; 2023Q4: 450,000 shares; 2024Q1: 450,000 shares; 2024Q2: 450,000 shares 450,000$1.84M0.1%0Timeline
TARAPROTARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 209,227 shares; 2023Q2: 209,227 shares; 2023Q3: 209,227 shares; 2023Q4: 209,227 shares; 2024Q1: 209,227 shares; 2024Q2: 811,627 shares 811,627$1.69M0.09%+602,400Timeline
ATARA BIOTHERAPEUTICS INC C…ATARA BIOTHERAPEUTICS INC COM NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 4,150,000 shares; 2024Q2: 166,000 shares 166,000$1.41M0.07%-3,984,000
BCABBIOATLA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 686,347 shares; 2023Q2: 686,347 shares; 2023Q3: 686,347 shares; 2023Q4: 686,347 shares; 2024Q1: 686,347 shares; 2024Q2: 686,347 shares 686,347$940K0.05%0Timeline
MISTMILESTONE PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 698,861 shares; 2023Q2: 698,861 shares; 2023Q3: 309,007 shares; 2023Q4: 309,007 shares; 2024Q1: 309,007 shares; 2024Q2: 309,007 shares 309,007$408K0.02%0Timeline
DBV TECHNOLOGIES S ADBV TECHNOLOGIES S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,450,000 shares; 2023Q2: 1,450,000 shares; 2023Q3: 985,100 shares; 2023Q4: 500,000 shares; 2024Q1: 500,000 shares; 2024Q2: 250,000 shares 250,000$200K0.01%-250,000
NUVATION BIO INCNUVATION BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 266,666 shares; 2023Q2: 266,666 shares; 2023Q3: 266,666 shares; 2023Q4: 266,666 shares; 2024Q1: 266,666 shares; 2024Q2: 266,666 shares 266,666$42.7K<0.01%0
SRZNWSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 66,666 shares; 2023Q2: 66,666 shares; 2023Q3: 66,666 shares; 2023Q4: 66,666 shares; 2024Q1: 66,666 shares; 2024Q2: 66,666 shares 66,666$1.11K<0.01%0Timeline

Sold out in Q2 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
VKTXVIKING THERAPEUTICS INC300,000$24.6Mshares
DIREXION SHS ETF TRDIREXION SHS ETF TR350,000$2.55Mshares

How Q2 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000895345-24-000355 base2024-08-14acceptance time not in the bulk data set